Synthetic cannabinoids are a class of drugs designed to have similar structures and biological activities as the psychoactive components in cannabis. This encompasses a wide range of structural variants, and their potencies and toxicities are not fully understood. This trade publication piece summarizes the history of synthetic cannabinoids and highlights the ongoing challenge they present to public health and interdiction efforts.
Downloads
Similar Publications
- Eutylone (bk-EBDB) and Benzylone (BMDP): Increasing Prevalence of New Synthetic Stimulants in the United States
- The Edge of Stigma: An Experimental Audit of the Effects of Low-Level Criminal Records on Employment
- Where do sex crimes occur? How an examination of sex offense location can inform policy and prevention